	Impact of Simulated Radiation Dose Reduction on Deep Learning-Based Renal Segmentation Performance: A Simulation Study Using the KiTS21 (2021 Kidney and Kidney Tumor Segmentation Challenge) Dataset. Int Neurourol J Kim JS, Eun SJ. PMID: 42252648 [PubMed]
	Consolidative therapy for PSMA-avid lesions after 3 cycles of apalutamide plus androgen deprivation in metastatic hormone-sensitive prostate cancer: A prospective phase 2 single-arm trial. Eur J Nucl Med Mol Imaging Pan J, Wang B, Zhu B, Gan H, Hu X, Liu X, Li X, Wu J, Wang H, Zhang Q, Liu C, Song S, Ma X, Ye D, Zhu Y. PMID: 42252348 [PubMed - as supplied by publisher]
	Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer. Discov Oncol Feng W, He W. PMID: 42251607 [PubMed - as supplied by publisher]
	Multi-dimensional profiling of lactylation-related signatures for prognostic and therapeutic insights in bladder cancer. Cancer Cell Int Zhao H, Li K, Xu H, Liao J, Zhuo C, Wang Q, Liu X, Kang Z, Zhu B, Lai X, Zhu S, Zhang Y, Zeng J. PMID: 42251369 [PubMed - as supplied by publisher]
	Diagnostic value of PSA-based markers in prostate cancer: a retrospective analysis stratified by body mass index. BMC Urol Yang T, Zhang Q, Liu Z, Tian J, Hu X, Lv Z. PMID: 42251295 [PubMed - as supplied by publisher]
	Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer. Ann Oncol Parker CTA, Huang HC, Grist E, Mendes L, Yamashita R, Croucher D, Sachdeva A, Murphy L, Liu VYT, Vidal SS, Todorovic T, Lall S, Goncalves M, Thakali S, Wingate A, Zakka L, Wetterskog D, Nowakowska K, Amos CL, STAMPEDE Collaborators, Berney DM, Tran PT, Spratt DE, Sydes MR, Brown LC, Zhao SG, Nguyen P, Clarke NW, Sweeney CJ, Stewart EL, Parmar MKB, Esteva A, James ND, Attard G. PMID: 42250604 [PubMed - as supplied by publisher]
	Glycovariant-based diagnosis of bladder cancer using urinary mucin 1 and carcinoembryonic antigen. J Pharm Biomed Anal Syed P, Islam MK, Kekki H, Terävä J, Lamminmäki U, Boström PJ, Leivo J, Gidwani K. PMID: 42250336 [PubMed - as supplied by publisher]
	Identification and external validation of a prognostic signature based on bone morphogenetic protein-related mRNAs for kidney renal clear cell carcinoma. Discov Oncol Zhou Y, Hu Z, Xie L, Zhang S, Huang Q, Zhang N, Liu Y, Zhang W, Wang K. PMID: 42250062 [PubMed - as supplied by publisher]
	Microstructure imaging of prostate cancer by diffusion MRI. MAGMA Szczepankiewicz F, Panagiotaki E, Molendowska M, Sandeman K, Palombo M, Wu D. PMID: 42250048 [PubMed - as supplied by publisher]
	Impact of CKD on perioperative outcomes following TURBT: a national NSQIP analysis. World J Urol Touma Sawaya R, Nasrallah O, El Hajj A, Abdessater M. PMID: 42249173 [PubMed - indexed for MEDLINE]
	Enhancing foundation model transfer for prostate cancer detection with patch-level contrastive learning. NPJ Digit Med Lee JH, Li CX, Jahanandish H, Bhattacharya I, Vesal S, Song Y, Zhang L, Sang S, Choi MH, Soerensen SJC, Zhou SR, Sommer ER, Seibert TM, Fan R, Ghanouni P, Sonn GA, Rusu M. PMID: 42249085 [PubMed - as supplied by publisher]
	Epigenetic modulation of prostate cancer disparities in men with African ancestry. Nat Rev Urol Craddock J, Hayes VM. PMID: 42249067 [PubMed - as supplied by publisher]
	Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study. Eur J Surg Oncol Filzmayer M, Quarta L, Petix M, Orlandi F, Goyal JA, Briganti A, Carmignani L, Micali S, Shariat SF, Kosiba M, Humke C, Saad F, Chun FK, Karakiewicz PI. PMID: 42247963 [PubMed - as supplied by publisher]
	Artificial intelligence in prostate cancer imaging: A mini-review of current applications and future directions. Urol Oncol Ergül MA, Sabur V. PMID: 42247882 [PubMed - as supplied by publisher]
	Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer. Urol Oncol Yajima S, Yoshida S, Chen W, Fukushima H, Tanaka H, Sato H, Hirakawa A, Masuda H, Fujii Y. PMID: 42247881 [PubMed - as supplied by publisher]
	Real-world outcomes of definitive chemoradiotherapy for bladder cancer: a multi-institutional retrospective study in Japan. Jpn J Clin Oncol Sugahara D, Murofushi KN, Yamashita H, Ogo E, Kikuchi K, Saito AI, Komiyama T, Imano N, Igarashi A, Ohno S, Onishi H. PMID: 42247594 [PubMed - as supplied by publisher]
	Integrative Biology Approaches Uncover Plasticizers' Pro-Carcinogenic Role in Prostate Cancer via Molecular Docking and Network Toxicology. OMICS Huang J, Huang Y, Huang Y, Lin Z, Liao L, Yang L, Chen S. PMID: 42247313 [PubMed - as supplied by publisher]
	Precise zonal diagnosis: multi-b-value DWI model reveals differential predictors of clinically significant prostate cancer in peripheral and transition zones. Insights Imaging He K, Chen Y, Kang Z, Li S, Gao M, Yin T, Chen W, Darwish O, Li Z. PMID: 42247047 [PubMed]
	Costing the national clinical guidelines for prostate cancer control and management in South Africa: Public sector perspective. S Afr Med J Thsehla E, Khoza M, Boachie MK, Mdewa W, Goldstein S, Somaroo H, Hofman KJ. PMID: 42246791 [PubMed - indexed for MEDLINE]
	Toward the genetic landscape of prostate cancer in India: insights from whole-exome and low-pass whole-genome sequencing of formalin-fixed paraffin-embedded tumor tissues. Front Syst Biol Biswas S, Rajarathinam B, Khilwani B, Jalendra G, Sharma D, Vijavargiya M, Aradhya R, Ansari AS, Shukla N, Chaubey G, Lohiya NK, Suravajhala P, CA Prostate Consortium of India (CAPCI). PMID: 42246034 [PubMed]

Articles 1 - 20 / 178766

Page 1 of 8939



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy